pittsburgh dihexa therapy EB Research Partnership | ZEVASKYN® (prademagene zamikeracel), an FDA-approved gene-modified cellular sheet therapy, is now available at The University of Texas

Quick Dispatch:

Your pittsburgh dihexa therapy EB Research Partnership | ZEVASKYN® (prademagene zamikeracel), an FDA-approved gene-modified cellular sheet therapy, is now available at The University of Texas orders ship within 1-2 business days.

Delivery Options:

• Standard: 3-7 business days
• Fast: 2-3 business days
• Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your pittsburgh dihexa therapy EB Research Partnership | ZEVASKYN® (prademagene zamikeracel), an FDA-approved gene-modified cellular sheet therapy, is now available at The University of Texas ships.

Need Help?
Questions about pittsburgh dihexa therapy EB Research Partnership | ZEVASKYN® (prademagene zamikeracel), an FDA-approved gene-modified cellular sheet therapy, is now available at The University of Texas, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for pittsburgh dihexa therapy EB Research Partnership | ZEVASKYN® (prademagene zamikeracel), an FDA-approved gene-modified cellular sheet therapy, is now available at The University of Texas in your area.